[PDF][PDF] Understanding the effect of glycemic control on macrovascular outcomes in patients with diabetes using the Archimedes Model
P Alperin, G Soto-Campos, B Peskin, A Shcheprov… - Diabetes, 2010 - researchgate.net
P Alperin, G Soto-Campos, B Peskin, A Shcheprov, T van Nguyen, J Noah-Vanhoucke…
Diabetes, 2010•researchgate.net… • The value of intensive glycemic control in preventing macrovascular outcomes in
populations with type 2 diabetes (T2DM) is not clear. • Studies designed to address this
question – such as UKPDS80, ADVANCE, PROactive, ACCORD, and VADT – have yielded
a mixed picture on the relative benefit of intensive … • Summary: Post-trial monitoring
following on UKPDS 33/34, investigating whether improved glucose control seen at the end
of those trials would persist and whether such therapy had a long-term effect on …
populations with type 2 diabetes (T2DM) is not clear. • Studies designed to address this
question – such as UKPDS80, ADVANCE, PROactive, ACCORD, and VADT – have yielded
a mixed picture on the relative benefit of intensive … • Summary: Post-trial monitoring
following on UKPDS 33/34, investigating whether improved glucose control seen at the end
of those trials would persist and whether such therapy had a long-term effect on …
Background Objectives of this Study Validations using the Archimedes Model The Trials Validation Results Discussion Conclu
researchgate.net